StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Evogene Price Performance Shares of EVGN stock opened at $0.77 on Friday. The company has a market capitalization of $31.73 million, a PE ratio of -1.67 […]
Evogene Ltd. (NASDAQ:EVGN) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating.
Conference call and webcast: today, May 23, 2024, 9:00 am ET
Financial and Business Highlights:
Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.
Q1 2024 net loss:.